CORONAVIRUS/India COVID variant evades immune system more easily: Academia Sinica

06/01/2021 02:04 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
New Delhi. Anadolu Agency photo May 16, 2021
New Delhi. Anadolu Agency photo May 16, 2021

Taipei, June 1 (CNA) A coronavirus variant first detected in India has mutations that allows it to evade the human immune system more easily than other variants, Academia Sinica, Taiwan's leading research institution, said Monday.

Viruses of the B.1.617 lineage were first reported in India on Oct. 5, 2020 and they have since been found in over 40 countries, the institution's SARS-CoV-2 Variation Monitoring Network said in a report.

Of these B.1.617 mutations, two allow it to evade the immune system more effectively, and a third allows the virus to integrate with human cells more easily, which could enable it to spread faster, Academia Sinica said, citing data from the GISAID global science initiative databank.

Existing COVID-19 vaccines still provide protection against the Indian variant, however, though studies have found some reduction in effectiveness, the report said, citing an analysis from the World Health Organization.

Public Health England, a British government agency, said in late May that the Pfizer-BioNTech, Moderna and AstraZeneca vaccines are all "highly effective" against a subtype of the India variant, Academia Sinica said.

The Central Epidemic Command Center (CECC) has said previously that there are COVID-19 patients in Taiwan infected with viruses of the B.1.617 lineage, but these cases were all detected at Taiwan's borders.

(By Wu Hsin-yun and Chiang Yi-ching)


View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.